全球单克隆抗体在兽医保健市场研究报告 - 2023 年至 2030 年行业分析、规模、份额、增长、趋势和预测

全球兽医保健市场对单克隆抗体的需求预计将从 2022 年的 718.09 万美元达到 2030 年近 2741.58 万美元的市场规模，2023-2030 年研究期间复合年复合成长率为 18.23%。

兽医保健中的单克隆抗体（mAb）是指用于动物治疗各种疾病和病症的一种靶向疗法。这些是实验室生产的分子，旨在模仿免疫系统响应感染或其他异物而产生的天然抗体。

市场动态：

动物中癌症和自身免疫性疾病等慢性疾病的患病率正在上升，这推动了单克隆抗体等靶向和特异性疗法的采用。生物技术和基因工程的进步也提高了单克隆抗体的生产，提供更有效和专业的治疗。兽医的认识和接受度不断提高，加上临床试验的积极结果，促进了它们的普及。不断扩大的兽药行业、对个性化和靶向治疗的关注以及伴侣动物护理的改善进一步增加了对这些抗体的需求。此外，监管部门的批准以及研究机构和製药公司之间的合作加速了单克隆抗体在兽医健康领域的开发和可及性。随着技术的成熟和成本变得更加易于管理，市场预计将持续增长，为动物提供新的和创新的治疗选择。

该研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具还对全球兽医健康单克隆抗体市场的各个细分市场进行了包容性评估。兽医保健行业单克隆抗体的增长和趋势为本研究提供了整体方法。

区域分析：

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲兽医保健市场单克隆抗体当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。兽医保健单克隆抗体市场的主要参与者包括 Zoetis、Merck & Co, Inc.、Elanco、Boehringer Ingelheim GmbH、Indian Immunologicals Ltd、Virbac。本节包含竞争格局的整体视图，包括各种战略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何定制要求，请写信给我们。我们的研究团队可以根据您的需求提供定制报告。

目录

第一章：前言

• 报告说明
  • 客观的
  • 目标听众
  • 独特的销售主张 (USP) 和产品
• 研究范围
• 研究方法论
  • 市场研究过程
  • 市场研究方法论

第 2 章：执行摘要

• 市场亮点
• 全球市场概况

第 3 章：单克隆抗体在兽医健康领域的应用 - 行业分析

• 简介 - 市场动态
• 市场驱动因素
• 市场限制
• 机会
• 行业动态
• 波特五力分析
• 市场吸引力分析
  • 按动物类型分類的市场吸引力分析
  • 市场吸引力分析：按应用分类
  • 最终用户的市场吸引力分析
  • 市场吸引力分析：按地区

第 4 章：价值链分析

• 价值链分析
• 原材料分析
  • 原材料清单
  • 原料厂商清单
  • 主要原材料价格走势
• 潜在买家名单
• 营销渠道
  • 直销
  • 间接营销
  • 营销渠道发展趋势

第 5 章：全球兽医保健单克隆抗体市场分析：按动物类型

• 按动物类型概述
• 历史和预测数据
• 按动物类型分析
• 小狗
• 其他的

第 6 章：兽医保健市场中的全球单克隆抗体分析：按应用分类

• 概述：按应用
• 历史和预测数据
• 分析：按应用
• 皮肤科
• 疼痛
• 其他的

第 7 章：兽医保健市场中的全球单克隆抗体分析：按最终用户

• 最终用户概述
• 历史和预测数据
• 最终用户分析
• 兽医医院
• 其他的

第 8 章：兽医保健市场中的全球单克隆抗体分析：按地理位置

• 区域展望
• 介绍
• 北美销售分析
  • 概览、历史和预测数据销售分析
  • 北美按细分市场销售分析
  • 北美按国家/地区销售分析
  • 美国销售分析
  • 加拿大销售分析
  • 墨西哥销售分析
• 欧洲销售分析
  • 概览、历史和预测数据销售分析
  • 欧洲按细分市场销售分析
  • 欧洲按国家/地区销售分析
  • 英国销售分析
  • 法国销售分析
  • 德国销售分析
  • 意大利销售分析
  • 俄罗斯销售分析
  • 欧洲其他地区销售分析
• 亚太地区销售分析
  • 概览、历史和预测数据销售分析
  • 亚太地区按细分市场销售分析
  • 亚太地区国家/地区销售分析
  • 中国销售分析
  • 印度销售分析
  • 日本销售分析
  • 韩国销售分析
  • 澳大利亚销售分析
  • 东南亚销售分析
  • 亚太地区其他地区销售分析
• 拉丁美洲销售分析
  • 概览、历史和预测数据销售分析
  • 拉丁美洲按细分市场销售分析
  • 拉丁美洲按国家/地区销售分析
  • 巴西销售分析
  • 阿根廷销售分析
  • 秘鲁销售分析
  • 智利销售分析
  • 拉丁美洲其他地区销售分析
• 中东和非洲销售分析
  • 概览、历史和预测数据销售分析
  • 中东和非洲按细分市场销售分析
  • 中东和非洲国家销售分析
  • 沙特阿拉伯销售分析
  • 阿联酋销售分析
  • 以色列销售分析
  • 南非销售分析
  • 中东其他地区和非洲销售分析

第 9 章：兽医保健公司单克隆抗体的竞争格局

• 兽医保健市场竞争中的单克隆抗体
• 伙伴关係/协作/协议
• 併购
• 新产品发布
• 其他发展

第 10 章：公司简介

• 公司股份分析
• 市场集中度
• Zoetis
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Merck & Co Inc.
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Elanco
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Boehringer Ingelheim GmbH
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Indian Immunologicals Ltd
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Virbac
• 公司简介
• 公司收入
• 产品
• 最近的发展

注意 - 在公司概况中，财务详细信息和近期发展视情况而定，或者如果是私营公司，则可能不包括在内

The global demand for Monoclonal Antibodies in Veterinary Health Market is presumed to reach the market size of nearly USD 2741.58 MN by 2030 from USD 718.09 MN in 2022 with a CAGR of 18.23% under the study period 2023 - 2030.

Monoclonal antibodies (mAbs) in veterinary health refer to a type of targeted therapy used in animals to treat various diseases and conditions. These are laboratory-produced molecules designed to mimic the natural antibodies that the immune system produces in response to infections or other foreign substances.

MARKET DYNAMICS:

The prevalence of chronic diseases in animals, such as cancer and autoimmune disorders, is rising, which is driving the adoption of targeted and specific therapies like mAbs. Biotechnology and genetic engineering advancement have also improved the production of mAbs, offering more effective and specialized treatments. Growing awareness and acceptance among veterinarians, coupled with positive outcomes from clinical trials, have contributed to their popularity. The expanding veterinary pharmaceutical industry, focus on personalized and targeted therapies and improved companion animal care have further boosted the demand for these antibodies. Additionally, regulatory approvals and collaborations between research institutes and pharmaceutical companies have accelerated the development and accessibility of mAbs in veterinary health. As the technology matures and costs become more manageable, the market is expected to witness continued growth, offering new and innovative treatment options for animals.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of monoclonal antibodies in veterinary health. The growth and trends of monoclonal antibodies in veterinary health industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the monoclonal antibodies in veterinary health market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Animal Type

• Dogs
• Others

By Application

• Dermatology
• Pain
• Others

By End-User

• Veterinary Hospitals
• Others

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Monoclonal Antibodies in Veterinary Health market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Monoclonal Antibodies in Veterinary Health market include Zoetis, Merck & Co, Inc., Elanco, Boehringer Ingelheim GmbH, Indian Immunologicals Ltd, Virbac. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

• 1.1. Report Description
  • 1.1.1. Objective
  • 1.1.2. Target Audience
  • 1.1.3. Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1. Market Research Process
  • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3 . MONOCLONAL ANTIBODIES IN VETERINARY HEALTH - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Animal Type
  • 3.7.2 Market Attractiveness Analysis By Application
  • 3.7.3 Market Attractiveness Analysis By End-user
  • 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1. List of Raw Materials
  • 4.2.2. Raw Material Manufactures List
  • 4.2.3. Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1. Direct Marketing
  • 4.4.2. Indirect Marketing
  • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL MONOCLONAL ANTIBODIES IN VETERINARY HEALTH MARKET ANALYSIS BY ANIMAL TYPE

• 5.1 Overview by Animal Type
• 5.2 Historical and Forecast Data
• 5.3 Analysis by Animal Type
• 5.4 Dogs Historic and Forecast Sales by Regions
• 5.5 Others Historic and Forecast Sales by Regions

6 . GLOBAL MONOCLONAL ANTIBODIES IN VETERINARY HEALTH MARKET ANALYSIS BY APPLICATION

• 6.1 Overview by Application
• 6.2 Historical and Forecast Data
• 6.3 Analysis by Application
• 6.4 Dermatology Historic and Forecast Sales by Regions
• 6.5 Pain Historic and Forecast Sales by Regions
• 6.6 Others Historic and Forecast Sales by Regions

7 . GLOBAL MONOCLONAL ANTIBODIES IN VETERINARY HEALTH MARKET ANALYSIS BY END-USER

• 7.1 Overview by End-user
• 7.2 Historical and Forecast Data
• 7.3 Analysis by End-user
• 7.4 Veterinary Hospitals Historic and Forecast Sales by Regions
• 7.5 Others Historic and Forecast Sales by Regions

8 . GLOBAL MONOCLONAL ANTIBODIES IN VETERINARY HEALTH MARKET ANALYSIS BY GEOGRAPHY

• 8.1. Regional Outlook
• 8.2. Introduction
• 8.3. North America Sales Analysis
  • 8.3.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.3.2. North America By Segment Sales Analysis
  • 8.3.3. North America By Country Sales Analysis
  • 8.3.4. United State Sales Analysis
  • 8.3.5. Canada Sales Analysis
  • 8.3.6. Mexico Sales Analysis
• 8.4. Europe Sales Analysis
  • 8.4.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.4.2. Europe by Segment Sales Analysis
  • 8.4.3. Europe by Country Sales Analysis
  • 8.4.4. United Kingdom Sales Analysis
  • 8.4.5. France Sales Analysis
  • 8.4.6. Germany Sales Analysis
  • 8.4.7. Italy Sales Analysis
  • 8.4.8. Russia Sales Analysis
  • 8.4.9. Rest Of Europe Sales Analysis
• 8.5. Asia Pacific Sales Analysis
  • 8.5.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.5.2. Asia Pacific by Segment Sales Analysis
  • 8.5.3. Asia Pacific by Country Sales Analysis
  • 8.5.4. China Sales Analysis
  • 8.5.5. India Sales Analysis
  • 8.5.6. Japan Sales Analysis
  • 8.5.7. South Korea Sales Analysis
  • 8.5.8. Australia Sales Analysis
  • 8.5.9. South East Asia Sales Analysis
  • 8.5.10. Rest Of Asia Pacific Sales Analysis
• 8.6. Latin America Sales Analysis
  • 8.6.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.6.2. Latin America by Segment Sales Analysis
  • 8.6.3. Latin America by Country Sales Analysis
  • 8.6.4. Brazil Sales Analysis
  • 8.6.5. Argentina Sales Analysis
  • 8.6.6. Peru Sales Analysis
  • 8.6.7. Chile Sales Analysis
  • 8.6.8. Rest of Latin America Sales Analysis
• 8.7. Middle East & Africa Sales Analysis
  • 8.7.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.7.2. Middle East & Africa by Segment Sales Analysis
  • 8.7.3. Middle East & Africa by Country Sales Analysis
  • 8.7.4. Saudi Arabia Sales Analysis
  • 8.7.5. UAE Sales Analysis
  • 8.7.6. Israel Sales Analysis
  • 8.7.7. South Africa Sales Analysis
  • 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE MONOCLONAL ANTIBODIES IN VETERINARY HEALTH COMPANIES

• 9.1. Monoclonal Antibodies In Veterinary Health Market Competition
• 9.2. Partnership/Collaboration/Agreement
• 9.3. Merger And Acquisitions
• 9.4. New Product Launch
• 9.5. Other Developments

10 . COMPANY PROFILES OF MONOCLONAL ANTIBODIES IN VETERINARY HEALTH INDUSTRY

• 10.1. Company Share Analysis
• 10.2. Market Concentration Rate
• 10.3. Zoetis
  • 10.3.1. Company Overview
  • 10.3.2. Company Revenue
  • 10.3.3. Products
  • 10.3.4. Recent Developments
• 10.4. Merck & Co Inc.
  • 10.4.1. Company Overview
  • 10.4.2. Company Revenue
  • 10.4.3. Products
  • 10.4.4. Recent Developments
• 10.5. Elanco
  • 10.5.1. Company Overview
  • 10.5.2. Company Revenue
  • 10.5.3. Products
  • 10.5.4. Recent Developments
• 10.6. Boehringer Ingelheim GmbH
  • 10.6.1. Company Overview
  • 10.6.2. Company Revenue
  • 10.6.3. Products
  • 10.6.4. Recent Developments
• 10.7. Indian Immunologicals Ltd
  • 10.7.1. Company Overview
  • 10.7.2. Company Revenue
  • 10.7.3. Products
  • 10.7.4. Recent Developments
• 10.8. Virbac
  • 10.8.1. Company Overview
  • 10.8.2. Company Revenue
  • 10.8.3. Products
  • 10.8.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

• Market Snapshot
• Drivers : Impact Analysis
• Restraints : Impact Analysis
• List of Raw Material
• List of Raw Material Manufactures
• List of Potential Buyers
• Analysis by Animal Type (USD MN)
• Dogs Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Analysis Market by Application (USD MN)
• Dermatology Market Sales by Geography (USD MN)
• Pain Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Analysis by End-user (USD MN)
• Veterinary Hospitals Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Global Monoclonal Antibodies In Veterinary Health Market Sales by Geography (USD MN)
• North America Market Analysis (USD MN)
• United State Market Analysis (USD MN)
• Canada Market Analysis (USD MN)
• Mexico Market Analysis (USD MN)
• Europe Market Analysis (USD MN)
• Europe Market Estimate by Country (USD MN)
• United Kingdom Market Analysis (USD MN)
• France Market Analysis (USD MN)
• Germany Market Analysis (USD MN)
• Italy Market Analysis (USD MN)
• Russia Market Analysis (USD MN)
• Spain Market Analysis (USD MN)
• Rest of Europe Market Analysis (USD MN)
• Asia Pacific Market Analysis (USD MN)
• China Market Analysis (USD MN)
• Japan Market Analysis (USD MN)
• India Market Analysis (USD MN)
• South Korea Market Analysis (USD MN)
• Australia Market Analysis (USD MN)
• South East Asia Market Analysis (USD MN)
• Rest of Asia Pacific Market Analysis (USD MN)
• Latin America Market Analysis (USD MN)
• Brazil Market Analysis (USD MN)
• Argentina Market Analysis (USD MN)
• Peru Market Analysis (USD MN)
• Chile Market Analysis (USD MN)
• Rest of Latin America Market Analysis (USD MN)
• Middle East & Africa Market Analysis (USD MN)
• Saudi Arabia Market Analysis (USD MN)
• UAE Market Analysis (USD MN)
• Israel Market Analysis (USD MN)
• South Africa Market Analysis (USD MN)
• Rest of Middle East and Africa Market Analysis (USD MN)
• Partnership/Collaboration/Agreement
• Mergers And Acquisition

LIST OF FIGURES

• Research Scope of Monoclonal Antibodies In Veterinary Health Report
• Market Research Process
• Market Research Methodology
• Global Monoclonal Antibodies In Veterinary Health Market Size, by Region (USD MN)
• Porters Five Forces Analysis
• Market Attractiveness Analysis by Animal Type
• Market Attractiveness Analysis by Application
• Market Attractiveness Analysis by End-user
• Market Attractiveness Analysis by Region
• Value Chain Analysis
• Global Market Analysis by Animal Type (USD MN)
• Dogs Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Global Market Analysis by Application (USD MN)
• Dermatology Market Sales by Geography (USD MN)
• Pain Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Global Market Analysis by End-user (USD MN)
• Veterinary Hospitals Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Global Market Sales (USD MN)
• North America Market Sales (USD MN)
• Europe Market Sales (USD MN)
• Asia Pacific Market Sales (USD MN)
• Latin America Market Sales (USD MN)
• Middle East & Africa Market Sales (USD MN)
• Recent Development in Industry
• Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.